26 research outputs found
Resection of a methicillin-resistant Staphylococcus aureus liver abscess in a patient with Crohn’s disease under infliximab treatment: a case report
Full text linkT1051 Clinical Efficacy of Infliximab in the Management of Postsurgical Recurring Crohn's Disease
No full textAbsence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease
No full textSu1125 Long-Term Efficacy of a pH-Dependent Release Mesalamine Formulation, Asacol in Patients With Ulcerative Colitis Who Showed Inadequate Response to a Time-Dependent Release Mesalamine Formulation, Pentasa: A Prospective Study
No full textA Case of Human Leukocyte Antigen (HLA) B27-Positive Intestinal Behçet's Disease with Crohn's Disease-Like Anal Fistulas
No full textA 49-year-old male was admitted to our hospital with complaints of perianal pain, bloody stool, and high-grade fever due to perianal abscess. Drainage was carried out; however, the patient's complaints worsened, and biopsy findings of colonoscopy showed ulcerative colitis-like lesions. The patient was diagnosed as having Behçet's disease with intestinal involvement, did not have HLA-B51, but did have HLA-B27. We describe a case of Behcet's disease with colitis, making a differential diagnosis of inflammatory bowel disease difficult
Sa1132 Comparative Short- Term Efficacy of Cyclosporine, Tacrolimus and Infliximab in Hospitalized Patients With Severe Corticosteroid-Refractory Ulcerative Colitis: A Retrospective Study
No full textS1048 The Impact of Processed Blood Volume On the Clinical Efficacy of Adsorptive Depletion of Myeloid Leukocytes in Patients with Ulcerative Colitis
No full textSa1112 Long-Term Efficacy of a pH-Dependent Release Mesalamine Formulation, Asacol in Patients With Ulcerative Colitis Who Showed Inadequate Response to a Time- Dependent Release Mesalamine Formulation, Pentasa: A Prospective study
No full textS1042 The Association of Processed Blood Volume With the Clinical Efficacy of Selective Adsorption of Elevated Myeloid Leucocytes in Patients With Ulcerative Colitis
No full textS1066 Oral Alpha-4 Integrin Inhibitor (AJM300) in Patients with Active Crohn's Disease — A Randomized, Double-Blind, Placebo-Controlled Trial
No full text
